1. Home
  2. MNOV vs JSPR Comparison

MNOV vs JSPR Comparison

Compare MNOV & JSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MNOV
  • JSPR
  • Stock Information
  • Founded
  • MNOV 2000
  • JSPR 2018
  • Country
  • MNOV United States
  • JSPR United States
  • Employees
  • MNOV N/A
  • JSPR N/A
  • Industry
  • MNOV Biotechnology: Pharmaceutical Preparations
  • JSPR Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • MNOV Health Care
  • JSPR Health Care
  • Exchange
  • MNOV Nasdaq
  • JSPR Nasdaq
  • Market Cap
  • MNOV 65.7M
  • JSPR 47.6M
  • IPO Year
  • MNOV 2005
  • JSPR N/A
  • Fundamental
  • Price
  • MNOV $1.22
  • JSPR $2.33
  • Analyst Decision
  • MNOV Strong Buy
  • JSPR Buy
  • Analyst Count
  • MNOV 2
  • JSPR 12
  • Target Price
  • MNOV $7.00
  • JSPR $30.78
  • AVG Volume (30 Days)
  • MNOV 64.9K
  • JSPR 139.0K
  • Earning Date
  • MNOV 11-12-2025
  • JSPR 11-06-2025
  • Dividend Yield
  • MNOV N/A
  • JSPR N/A
  • EPS Growth
  • MNOV N/A
  • JSPR N/A
  • EPS
  • MNOV N/A
  • JSPR N/A
  • Revenue
  • MNOV $134,599.00
  • JSPR N/A
  • Revenue This Year
  • MNOV N/A
  • JSPR N/A
  • Revenue Next Year
  • MNOV N/A
  • JSPR N/A
  • P/E Ratio
  • MNOV N/A
  • JSPR N/A
  • Revenue Growth
  • MNOV N/A
  • JSPR N/A
  • 52 Week Low
  • MNOV $1.13
  • JSPR $2.27
  • 52 Week High
  • MNOV $2.55
  • JSPR $26.05
  • Technical
  • Relative Strength Index (RSI)
  • MNOV 37.71
  • JSPR 27.87
  • Support Level
  • MNOV $1.25
  • JSPR $2.32
  • Resistance Level
  • MNOV $1.38
  • JSPR $2.50
  • Average True Range (ATR)
  • MNOV 0.04
  • JSPR 0.14
  • MACD
  • MNOV -0.01
  • JSPR -0.01
  • Stochastic Oscillator
  • MNOV 0.00
  • JSPR 1.57

About MNOV Medicinova Inc

MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's strategies are to focus its developing activities on therapeutics for neurological disorders and fibrotic diseases.

About JSPR Jasper Therapeutics Inc.

Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.

Share on Social Networks: